Exmceuticals Inc
CNSX:EXM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clas Ohlson AB
STO:CLAS B
|
SE |
|
S
|
Suzhou Kematek Inc
SZSE:301611
|
CN |
|
Nandani Creation Ltd
NSE:JAIPURKURT
|
IN |
Exmceuticals Inc
Long-Term Debt
Exmceuticals Inc
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Exmceuticals Inc
CNSX:EXM
|
Long-Term Debt
CA$310k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Long-Term Debt
$20.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Long-Term Debt
CA$242.3m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
52%
|
|
|
Cronos Group Inc
TSX:CRON
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Long-Term Debt
$40.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Long-Term Debt
CA$57.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
87%
|
CAGR 10-Years
N/A
|
|
Exmceuticals Inc
Glance View
EXMceuticals, Inc. is a pharmaceutical biosciences company, which engages in producing therapeutic cannabis. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-01-31. The firm operates through its geographic segments, which include Canada, Portugal, Uganda and Netherlands. The Company’s subsidiaries include EXMceuticals Inc., EXMceuticals Holdings B.V, EXMceuticals Portugal, LDA and EXMceuticals Portugal II, Unipessoal Lda.
See Also
What is Exmceuticals Inc's Long-Term Debt?
Long-Term Debt
310k
CAD
Based on the financial report for Jun 30, 2020, Exmceuticals Inc's Long-Term Debt amounts to 310k CAD.